TidalHealth

Kevin Johnson

Clinical Informatics Authority

From Pharmacy Operations to Enterprise Strategy

Health systems are under increasing pressure to deliver excellent care while managing rising drug costs, payer complexity, margin compression, affordability concerns and expanding regulatory expectations. Few areas sit at the center of those challenges more directly than pharmacy.

For many years, pharmacy was often viewed through a narrower operating lens: procurement, dispensing, clinical review and medication safety. Those responsibilities remain foundational, but the role of pharmacy is changing. Today, pharmacy has the potential to become a data-driven enterprise platform that connects clinical care, financial sustainability, patient access, reimbursement capture, payer strategy and scalable operations.

In my role as Director of Ambulatory Pharmacy Services at TidalHealth, I have seen how this evolution is reshaping the work of pharmacy leadership. The most important decisions are no longer limited to where a medication is purchased or dispensed. They increasingly require leaders to determine the right clinical, financial, and operational, and access pathway for each therapy.

That distinction is especially important for high-cost medications. A single therapy decision can affect physician-practice expense, infusion capacity, pharmacy benefit versus medical benefit routing, prior authorization requirements, patient out-of-pocket exposure, revenue cycle workflows, acquisition cost, reimbursement performance, documentation requirements and compliance risk. If those decisions occur in silos, health systems may create avoidable costs, denials, and waste, or access barriers. When managed through an enterprise lens, those same decisions can become opportunities to improve both access and sustainability.

Technology-Enabled Pharmacy Decision Making

This is where technology, data and workflow design become essential. The differentiator is not simply whether a health system has pharmacy, infusion, specialty pharmacy, revenue cycle or payer expertise. It is whether those functions are connected by reliable data and usable workflows. Leaders need visibility into benefit pathway selection, authorization status, acquisition cost, expected reimbursement, denial risk, patient cost exposure, operational capacity and documentation before the medication is administered or dispensed.

Technology does not replace operational judgment. It makes the right decision easier to identify, repeat, measure and scale.

Optimizing Benefit Pathways for Sustainable Care

One of the most important shifts is moving from reactive medication management to proactive benefit and site-ofcare optimization. For some therapies, a pharmacy-benefitfirst model may lower patient cost, improve affordability and support a more efficient operating model. For others, medical benefit administration in an ambulatory infusion setting may be more appropriate. In many cases, the best model is not the one with the highest gross reimbursement, but the one that produces the best total outcome after acquisition cost, payer restrictions, fees, labor, denials, affordability and compliance are fully evaluated.

That is why pharmacy leaders must understand and communicate the full margin stack. Revenue alone does not tell the story. Sustainable performance requires evaluating revenue, acquisition cost, reimbursement, payer rules, fees, overhead, patient cost exposure, compliance and net margin. The role of pharmacy leadership is to make that complexity visible, measurable and actionable for the broader enterprise.

Building Sustainable Pharmacy Operations

This work also requires discipline. Financial opportunity should never be pursued without operational integrity. That is especially true in areas such as 340B, where health systems must balance mission-driven financial stewardship with eligibility discipline, documentation standards, auditable workflows and compliance oversight. Sustainable pharmacy strategy is not simply about capturing more value. It is about capturing appropriate value in a way the organization can defend, scale, and continuously improve.

Employee health plan pharmacy strategy is another example of pharmacy's expanding role. Health systems are not only providers of care.; They are also employers managing rising pharmacy spend. Pharmacy leaders can help evaluate benefit design, payer and pharmacy benefit manager alignment, internal prescription capture, formulary strategy, affordability programs and total cost of care.

“Technology does not replace operational judgment. It makes the right decision easier to identify, repeat, measure and scale.”

Driving Cross-Functional Collaboration across the Enterprise

The common thread across these efforts is cross-functional execution. Data must inform decisions. Technology must support workflows. Revenue cycle teams must understand billing implications. Patient access teams must understand benefit pathways. Clinical leaders must trust the model. Finance must be able to validate the impact. Compliance must be engaged early enough to shape the design rather than react after implementation.

The future of pharmacy leadership belongs to operators who can bridge these domains. Tomorrow's pharmacy executive must be fluent in clinical care, reimbursement, contracting, payer behavior, patient access, informatics, regulatory risk and operations. The most effective leaders will not define success by department-level metrics alone. They will define success by whether pharmacy helps the health system become more accessible, financially resilient, scalable and strategically aligned.

The Future of Enterprise Pharmacy Leadership

Pharmacy is no longer just a support function. It is a strategic operating platform. As healthcare continues to face margin pressure, payer complexity and rising pharmaceutical costs, health systems will need leaders who can connect clinical purpose with financial discipline and technology-enabled execution. That is the opportunity in front of pharmacy today: to move from managing medications to architecting sustainable models of care.

The next frontier of pharmacy leadership is not simply better pharmacy performance. It is enterprise value creation.